Lung Stent Market Synopsis:
Lung Stent Market Size Was Valued at USD 0.23 Billion in 2023, and is Projected to Reach USD 0.32 Billion by 2032, Growing at a CAGR of 4.90% From 2024-2032.
Lung Stent Market means the global market for products and services related to the design, manufacturing and supply of stents to be used for the management of numerous lung related ailments. Lung stents are commonly used to keep obstructions, which may result from conditions such as obstructive pulmonary diseases, tracheobronchial disorders or lung cancer, from blocking the air passages. These could be of metal; silicone or a combination of both which holds the word ‘hybrid’; These types of stents are fixed in the airways to prevent them from collapsing or being blocked to ensure free airflow and better breathing for the patient in question. Growing cases of lung diseases across the world are likely to drive the demand for this equipment in the future.
The global lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), lung cancer, asthma, and bronchi are ruling the market for lung stent due to continuous increasing cases around the world. This coupled with the increasing pollution levels and equally a raised smoking index, draws a picture showing continuing and rapidly raising incidences of respiratory diseases among admitted patients. This has created a great market for lung stents for patients who need their airways opened up in congested lungs. Moreover, improvements to the stent technology, in terms of biodegradable and drug-coated stent varieties, are broadening the use of these products.
The third important factor is the positive trends in the healthcare segment of the emerging countries. Asia-Pacific, Latin American, and Africa are currently under pocket to upgrade their health sectors that expand lung disease patients’ access to better technology treatments. This is driving the need for lung stents in these areas. In addition, the increasing number of elderly people globally as this population is most vulnerable to respiratory issues, there is the need for stents to treat chronic lung diseases thereby increasing market growth.
Lung Stent Market Trend Analysis:
Technological innovations.
-
Novelty in the lung stent market is also apparent with the growth of trends towards using the customized and biodegradable lung stents. It is also increasingly common to deliver stents based on the patient’s requirements, which means customized treatment. Notably, the use of biodegradable is increasing since these ones can be absorbed by the body and do not require more invasive interventions to be extracted. The increased use of IT systems is likely to improve patient experience and therefore boost the market’s growth.
- One other key development facility are witnessing is the boost in low-invasive methods, especially bronchoscopy for applying stents. In recent years, there are improved medical imaging and endoscopic technology, it has become common practice to use bronchoscopy for stent placement, patients can avoid suffering pain and have shorter hospital stay. The increase in popularity of minimally invasive procedures is likely to continue in the future because patients and physicians are interested in reducing the length of hospitalizations and improving the patient’s quality of life, thus providing a suitable basis for the development of lung stent market.
The rapid growth of the healthcare sector.
-
One of the drivers that can be seen as a opportunity is the high growth of the healthcare sector the emerging economies. Asian-Pacific, Latin-American and African nations are escalating their healthcare systems; diagnosis, advanced treatment for lung disorders is emerging hence the need to adopt efficient modes of prevention. The lungs stents market is likely to expand new opportunities for companies as people gain better access to health care services and develop greater awareness of respiratory diseases.
- Moreover, the global rise in the pediatric population suffering from respiratory diseases is another underutilized opportunity in lung stent. This makes it possible to use pediatric specific stents to fit the expanding demand in kids with congenital or acquired lung diseases. The above findings are an indication that firms that channel their resources to research and development targeting this specific sector have a likelihood of tapping into the market niche.
Lung Stent Market Segment Analysis:
Lung Stent Market Segmented on the basis of Product Type, Procedure Type, Application, End User, and Region
By Product Type, Metal Stents segment is expected to dominate the market during the forecast period
-
On the basis of product type, the lung stent market includes Metal Stents, Silicone Stents and Hybrid Stents. The endoprosthetics are mostly constructed out of stainless steel or nitinol, as these metals are extremely strong and pliable; the main goal while dealing with difficult conditions is to keep the airways open. Silicone stents are non-metallic and used when biocompatibility and ease of removal is desirable and patient’s require frequent stent changes. A current type of stent is a metal-silicone stent which has a metal base coated with silicone providing the strength of metallic stents and the flexibility of silicone stents without the complications associated with the two. Both types serve different purposes of treating several kinds of airway obstruction depending on the patients and their health states.
By Application, Malignant Diseases segment expected to held the largest share
-
Lung stent market is mainly classified by application to malignant diseases and benign diseases. Pathologic conditions include cancer illnesses such as lung cancer in which the aforesaid stents help to keep open those airways blocked by tumors. These stents offer an enhancement in breathing and offer only a form of relief for patients with cancer and obstructed airways. Benign diseases on the other hand are non-cancerous diseases like Chronic Obstructive Pulmonary Disease, asthma, or tracheobronchial stenosis. In such cases, lung stents for the management of inflammatory, fibrotic or other non-malignant associated airway strictures helps to restore the normal respiratory function of the clients with obstructive lung disease.
Lung Stent Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America region has the largest market share in the lung stent market, attributable for the advanced healthcare infrastructure and for the increasing incidence of lung diseases. This region has shown to have many specialized hospitals and many qualified doctors who can perform different complicated procedures including bronchoscopy for stent insertion. For the same reason, there is a high involvement rate in smoking in the United States and Canada, diseases caused by pollution, and an aging population that increases the demand for lung stents.
- Secondly, Americans share with Canadians and Mexicans strong leadership in global medical research and production innovations which is reflected in the analyzed market. Ongoing innovations in stent technology including the drug eluting and bioresorable stents, are being initiated by the key players in industry in the U.S. Moreover, reimbursement policies in lung stent procedures also entail a positive outlook which, combined with a clear provision for manufacturers to participate in the market, has made the region the global leader in the growth of the lung stent market.
Active Key Players in the Lung Stent Market
-
Boston Scientific Corporation (United States)
- Medtronic Plc (Ireland)
- Cook Medical (United States)
- Teleflex Incorporated (United States)
- Novatech SA (France)
- Merit Medical Systems, Inc. (United States)
- Endo-Flex GmbH (Germany)
- Efer Endoscopy (France)
- Taewoong Medical Co., Ltd. (South Korea)
- Micro-Tech (Nanjing) Co., Ltd. (China)
- Other Active Players
|
Lung Stent Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 0.21 Billion |
|
Forecast Period 2024-32 CAGR: |
4.90 % |
Market Size in 2032: |
USD 0.32 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Procedure |
|
||
|
By Application |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Lung Stent Market by Product Type
4.1 Lung Stent Market Snapshot and Growth Engine
4.2 Lung Stent Market Overview
4.3 Metal Stents
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Metal Stents: Geographic Segmentation Analysis
4.4 Silicone Stents
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Silicone Stents: Geographic Segmentation Analysis
4.5 Hybrid Stents
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Hybrid Stents: Geographic Segmentation Analysis
Chapter 5: Lung Stent Market by Procedure Type
5.1 Lung Stent Market Snapshot and Growth Engine
5.2 Lung Stent Market Overview
5.3 Bronchoscopy
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Bronchoscopy: Geographic Segmentation Analysis
5.4 Thoracotomy
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Thoracotomy: Geographic Segmentation Analysis
Chapter 6: Lung Stent Market by Application
6.1 Lung Stent Market Snapshot and Growth Engine
6.2 Lung Stent Market Overview
6.3 Malignant Diseases
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Malignant Diseases: Geographic Segmentation Analysis
6.4 Benign Diseases
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Benign Diseases: Geographic Segmentation Analysis
Chapter 7: Lung Stent Market by End User
7.1 Lung Stent Market Snapshot and Growth Engine
7.2 Lung Stent Market Overview
7.3 Hospitals
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals: Geographic Segmentation Analysis
7.4 Ambulatory Surgical Centers
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Ambulatory Surgical Centers: Geographic Segmentation Analysis
7.5 Specialty Clinics
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Specialty Clinics: Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Lung Stent Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 BOSTON SCIENTIFIC CORPORATION (UNITED STATES)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 MEDTRONIC PLC (IRELAND)
8.4 COOK MEDICAL (UNITED STATES)
8.5 TELEFLEX INCORPORATED (UNITED STATES)
8.6 NOVATECH SA (FRANCE)
8.7 MERIT MEDICAL SYSTEMS INC. (UNITED STATES)
8.8 ENDO-FLEX GMBH (GERMANY)
8.9 EFER ENDOSCOPY (FRANCE)
8.10 TAEWOONG MEDICAL CO. LTD. (SOUTH KOREA)
8.11 MICRO-TECH (NANJING) CO. LTD. (CHINA)
8.12 OTHER ACTIVE PLAYERS
Chapter 9: Global Lung Stent Market By Region
9.1 Overview
9.2. North America Lung Stent Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Product Type
9.2.4.1 Metal Stents
9.2.4.2 Silicone Stents
9.2.4.3 Hybrid Stents
9.2.5 Historic and Forecasted Market Size By Procedure Type
9.2.5.1 Bronchoscopy
9.2.5.2 Thoracotomy
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Malignant Diseases
9.2.6.2 Benign Diseases
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals
9.2.7.2 Ambulatory Surgical Centers
9.2.7.3 Specialty Clinics
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Lung Stent Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Product Type
9.3.4.1 Metal Stents
9.3.4.2 Silicone Stents
9.3.4.3 Hybrid Stents
9.3.5 Historic and Forecasted Market Size By Procedure Type
9.3.5.1 Bronchoscopy
9.3.5.2 Thoracotomy
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Malignant Diseases
9.3.6.2 Benign Diseases
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals
9.3.7.2 Ambulatory Surgical Centers
9.3.7.3 Specialty Clinics
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Lung Stent Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Product Type
9.4.4.1 Metal Stents
9.4.4.2 Silicone Stents
9.4.4.3 Hybrid Stents
9.4.5 Historic and Forecasted Market Size By Procedure Type
9.4.5.1 Bronchoscopy
9.4.5.2 Thoracotomy
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Malignant Diseases
9.4.6.2 Benign Diseases
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals
9.4.7.2 Ambulatory Surgical Centers
9.4.7.3 Specialty Clinics
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Lung Stent Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Product Type
9.5.4.1 Metal Stents
9.5.4.2 Silicone Stents
9.5.4.3 Hybrid Stents
9.5.5 Historic and Forecasted Market Size By Procedure Type
9.5.5.1 Bronchoscopy
9.5.5.2 Thoracotomy
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Malignant Diseases
9.5.6.2 Benign Diseases
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals
9.5.7.2 Ambulatory Surgical Centers
9.5.7.3 Specialty Clinics
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Lung Stent Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Product Type
9.6.4.1 Metal Stents
9.6.4.2 Silicone Stents
9.6.4.3 Hybrid Stents
9.6.5 Historic and Forecasted Market Size By Procedure Type
9.6.5.1 Bronchoscopy
9.6.5.2 Thoracotomy
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Malignant Diseases
9.6.6.2 Benign Diseases
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals
9.6.7.2 Ambulatory Surgical Centers
9.6.7.3 Specialty Clinics
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Lung Stent Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Product Type
9.7.4.1 Metal Stents
9.7.4.2 Silicone Stents
9.7.4.3 Hybrid Stents
9.7.5 Historic and Forecasted Market Size By Procedure Type
9.7.5.1 Bronchoscopy
9.7.5.2 Thoracotomy
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Malignant Diseases
9.7.6.2 Benign Diseases
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals
9.7.7.2 Ambulatory Surgical Centers
9.7.7.3 Specialty Clinics
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Lung Stent Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 0.21 Billion |
|
Forecast Period 2024-32 CAGR: |
4.90 % |
Market Size in 2032: |
USD 0.32 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Procedure |
|
||
|
By Application |
|
||
|
End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
